ACA
CERE
Avoro Capital Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,539,547
| Closed | -$308M | – | 42 |
|
|
2024
Q2 | $308M | Sell |
7,539,547
-16,008
| -0.2% | -$655K | 4.11% | 9 |
|
|
2024
Q1 | $319M | Hold |
7,555,555
| – | – | 3.73% | 11 |
|
|
2023
Q4 | $320M | Buy |
7,555,555
+6,600,000
| +691% | +$280M | 4.42% | 10 |
|
|
2023
Q3 | $20.9M | Buy |
+955,555
| New | +$20.9M | 0.33% | 32 |
|